Newborn Screening Identifies Congenital Disorders in U.S. Infants

A descriptive report outlines the use of newborn screening for identifying congenital disorders in infants across the United States. The report does not specify a study design, phase, or sample size. No comparator group was defined for the screening process.

The primary outcome was the identification of congenital disorders. However, no results, effect sizes, absolute numbers, or statistical measures were reported for this outcome. Secondary outcomes, follow-up duration, and safety or tolerability data were also not reported.

Key limitations include the absence of quantitative data, results, and a comparative framework. The practice relevance and funding sources were not disclosed. This report provides only a general description of the screening application without evidence of its performance or impact.